It is currently Sun Sep 24, 2017 5:47 pm

News News of Tcelna (Tovaxin)

Site map of Tcelna (Tovaxin) » Forum : Tcelna (Tovaxin)

A board to discuss Tcelna as a treatment for Multiple Sclerosis

Tovaxin and fatigue

Ok so my issue with MS is fatigue. I slept today for 4 hours. I take a vitamin that helps with it but even with all the other limitations, I want the fatigue gone.

One thing I've got the impression of is MS fatigue is gone with Tovaxin. Does it eliminate fatigue? They even had an animation on their site saying that. How is everyone doing with the fatigue? Heck with doing somersaults. Is anyone ...
Read more : Tovaxin and fatigue | Views : 6357 | Replies : 28


Peptides and Re-Tests / Trials

I was wondering, Opexa have made major improvements on the efficacy of Tovaxin by increasing the number of "Peptides" used, to identify MRTC's. In each case, they did not appear to be required to go back to Phase I trials.

Does this mean, that after it has gone through Phase III, they will be able to improve the process by increasing the number of Peptides without needing to go through the 3 phases of trial ...
Read more : Peptides and Re-Tests / Trials | Views : 5228 | Replies : 16


News on the Tovaxin Extension Trials

Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin™ for Multiple Sclerosis
June 21, 2007 09:19 AM Eastern Daylight Time

<shortened url>

Effectiveness Shown in Relapsing Remitting Subjects Across Both Phase I/II Dose Escalation and Extension Trials

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the development and commercialization of cell therapies, today announced positive top-line data in an open-label Phase I/II extension clinical trial of the investigational ...
Read more : News on the Tovaxin Extension Trials | Views : 2665 | Replies : 4


Tovaxin news release

June 21, 2007 09:19 AM Eastern Daylight Time
Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin™ for Multiple Sclerosis
Effectiveness Shown in Relapsing Remitting Subjects Across Both Phase I/II Dose Escalation and Extension Trials

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the development and commercialization of cell therapies, today announced positive top-line data in an open-label Phase I/II extension clinical trial of the investigational T-cell vaccine, ...
Read more : Tovaxin news release | Views : 2436 | Replies : 4


RESULTS WILL VARY!

Hi to all,

I cannot believe that some people are looking for results like I have had while on Tovaxin. That these people think they may be on placebo just because they have not seen similar improvements. I don’t think these people ever read my timeline, and if they did, they only saw what they wanted to see.

I have said over 100 times that the hope for Tovaxin is to stop the attacks. There ...
Read more : RESULTS WILL VARY! | Views : 27037 | Replies : 144


Tovaxin News

Greetings,
This recent press release from Opexa suggests that they may be improving their methods of making the vaccine. Hopefully, this will increase the efficacy of the current vaccine and, in the future, help get people into the Phase III study more quickly once it begins.

NHE

Opexa Presents Tovaxin™ Research at Federation of Clinical Immunology Societies Annual Meeting
June 11, 2007 07:00 AM Eastern Daylight Time

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a ...
Read more : Tovaxin News | Views : 2523 | Replies : 1


Tovaxin Users

Member havingms has proposed we put together an informational thread for Tovaxin users. If you are on/have been on Tovaxin therapy, please consider answering the following questions in this thread for the benefit of others.

Thanks!


• When did you receive your first vaccination?

• What dose did you receive? How many millions of cells?

• What was your overall experience? Did you get better or worse?

• What side effects did you notice?
Read more : Tovaxin Users | Views : 38863 | Replies : 96


Dr Zang

I think this article is about the Dr Zang who developed the T cell vaccination. Interesting that GSK have snapped him up - they are one of the big players.

GlaxoSmithKline Launches Chinese R&D Centre with Appointment of Head in Shanghai 24 May 2007

Jingwu Zang to lead work on neurogenerative diseases.


GlaxoSmithKline (GSK) today announced the appointment of Jingwu Zang to head a new GSK research and development centre in Shanghai, China. His ...
Read more : Dr Zang | Views : 3225 | Replies : 6


Greetings from Europe and waiting for tovaxin to start there

Hi everybody and congratulations for this very interesting forum.

I'm french and my girlfriend was recently diagnosed with MS. (we're both 22) My whole world was crushed away in two weeks as many of our life projects were questioned because of MS.

I started searching the Internet all I could find about the disease, especially treatments, and I eventually heard about Tovaxin, which seems to me very promising. Unfortunately, we're french and there's no tovaxin ...
Read more : Greetings from Europe and waiting for tovaxin to start there | Views : 3078 | Replies : 6


My Tovaxin Experience so far

Howdy all,

I have been watching what has been going on here at the Tovaxin forum with great interest but have remained silent on how things are going for me in the study. I received my third injection last Thursday so here is how things have gone for me.

I went in for my first treatment on March 23 and the whole deal was uneventful. As a side note, it was very important that the ...
Read more : My Tovaxin Experience so far | Views : 12040 | Replies : 59


 

Login  •  Register


Statistics

Total posts 239728 • Total topics 26175 • Total members 17436


Contact us | Terms of Service